摘要
Late-life depression is a common,chronic and recurring disorder. We performed a systematicreview of the published papers on the efficacy and safety of new antidepressants for treatment of late-lifedepression,including five selective serotonin reuptake inhibitors (SSRIs),venlafaxine,Duloxetin,Mirtazapine.
Late-life depression is a common,chronic and recurring disorder. We performed a systematicreview of the published papers on the efficacy and safety of new antidepressants for treatment of late-lifedepression,including five selective serotonin reuptake inhibitors (SSRIs),venlafaxine,Duloxetin,Mirtazapine.
出处
《中国处方药》
2005年第1期55-57,共3页
Journal of China Prescription Drug
